How an Activist Group Helped Torpedo MDMA Therapy
After more than three decades of planning and a $250 million investment, Lykos Therapeutics’ application for the first psychedelic drug to reach federal regulators was expected to be a shoo-in.…
Activist Investor Seeks to Oust U.S. Steel Chief Over Nippon Deal
After the United States blocked Nippon Steel’s bid for U.S. Steel, the Pittsburgh company is facing new pressure from an activist investor who is seeking to oust its leadership and…